EUVIMEDEUVIMED entdecken
Crossref

Feasibility and Preliminary Outcomes of Area Under the Concentration‐Time Curve ( AUC )‐Guided Tacrolimus and Mycophenolate Dosing in Pediatric Kidney Transplant Recipients

Song Lu, Pramath Kakodkar, Dan Zhang, Ahmed Mostafa, Fergall Magee, Keefe Davis, Fang Wu iD

Pediatric Transplantation · 2026

DOI: 10.1111/petr.70274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Song Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada. Hauptthemen laut MEDLINE: Tacrolimus, Mycophenolic Acid, Kidney Transplantation, Immunosuppressive Agents. Die Arbeit nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This pilot study evaluated the feasibility of integrating an immunosuppressant area under the concentration‐time curve (AUC) monitoring for tacrolimus and mycophenolic acid (MPA) into pediatric kidney transplantation care.

Methods

Dedicated test codes, an AUC requisition form, and a coordinated laboratory sampling process were established for tacrolimus and MPA AUC. AUC was calculated using the ISBA 3.0 Bayesian pharmacokinetic platform. AUC results were correlated with doses, trough concentrations (C 0 ), 3 h post‐dose concentrations (C 3h ), and clinical outcomes.

Results

The AUC protocol was successfully integrated into the routine clinical workflow. Tacrolimus AUC showed correlations with dose ( r = 0.85) and C 0 ( r = 0.82); similarly, MPA AUC showed correlation with dose ( r = 0.61) and C 3h ( r = 0.65). Of the 21 Tacrolimus AUC measurements, 76% were within the target range, and 24% were below the range. For MPA AUC measurements, 65% (13/20) were within the target range, 5% (1/20) were below the range, and 30% (6/20) were above the range. Following individual AUC measurements, the tacrolimus dose was adjusted after 43% (9/21) of measurements, and the mycophenolate mofetil (MMF) dose was adjusted after 50% (10/20) of measurements.

Conclusion

This AUC pilot study demonstrated the feasibility of integrating AUC‐guided monitoring into the routine management of pediatric kidney transplant recipients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusMycophenolic AcidKidney TransplantationImmunosuppressive AgentsHumansChildPilot ProjectsArea Under CurveFeasibility StudiesFemaleMaleChild, PreschoolAdolescentDrug MonitoringTreatment OutcomeGraft RejectionInfantBayes Theorem

Stichwörter der Autor:innen

AUCmycophenolic acidpediatric kidney transplanttacrolimus

Substanzen

TacrolimusMycophenolic AcidImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada.
  • University of Saskatchewan College of Medicine, Saskatoon, Saskatchewan, Canada.
  • Department of Pediatric Nephrology, Saskatchewan Health Authority, Saskatoon, Saskatchewan, Canada.
  • Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Fang Wu

Zitieren

APA

Lu, S., Kakodkar, P., Zhang, D., Mostafa, A., Magee, F., Davis, K., & Wu, F. (2026). Feasibility and Preliminary Outcomes of Area Under the Concentration‐Time Curve ( AUC )‐Guided Tacrolimus and Mycophenolate Dosing in Pediatric Kidney Transplant Recipients. Pediatric Transplantation. https://doi.org/10.1111/petr.70274

Vancouver

Lu S, Kakodkar P, Zhang D, Mostafa A, Magee F, Davis K, et al. Feasibility and Preliminary Outcomes of Area Under the Concentration‐Time Curve ( AUC )‐Guided Tacrolimus and Mycophenolate Dosing in Pediatric Kidney Transplant Recipients. Pediatric Transplantation. 2026. doi:10.1111/petr.70274

BibTeX
@article{Lu2026,
  author = {Lu, Song and Kakodkar, Pramath and Zhang, Dan and Mostafa, Ahmed and Magee, Fergall and Davis, Keefe and Wu, Fang},
  title = {Feasibility and Preliminary Outcomes of Area Under the Concentration‐Time Curve ( AUC )‐Guided Tacrolimus and Mycophenolate Dosing in Pediatric Kidney Transplant Recipients},
  journal = {Pediatric Transplantation},
  year = {2026},
  doi = {10.1111/petr.70274}
}
Kostenlos starten →